YUMC Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower IIPR Q1 2026 Earnings EPS Misses Estimates Amid Persistent Cannabis Sector Headwinds SRPT Q1 2026 Earnings EPS Surges 18467 Above Estimates Amid Strong Gene Therapy Progress Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines VSTS Q1 2026 Earnings Massive EPS Beat Drives Investor Scrutiny Amid Revenue Discretion CVGI Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment APEI Q1 2026 Earnings EPS Soars Past Estimates Stock Dips Slightly JAGX Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges LOB Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Pullback FITBP Q1 2026 Earnings Strong EPS Beat of 3509 Surprise Drives Modest Stock Gain CF Q1 2026 Earnings Strong Earnings Beat Amid Stable Fertilizer Market MCS Q1 2026 Earnings NarrowerThanExpected Loss Offers Modest Relief